biomeafusion.com (BMEA): Volume dana dhuwit perusahaan

Logo grafis Biomea Fusion (BMEA)

High R&D expenses and FDA regulatory complexities create risks of capital dilution. The cash reserve metric visualizes the burn rate, where 0.03 determines the latest valuation figure. Liquidity relies on the development of the BMF-219 drug for diabetes therapy, however, global supply chain instability and overseas patent disputes complicate the financial stability of Biomea Fusion, Inc. (BMEA).

BMEA - Aset likuid perusahaan Biomea ing rentang 04.07.2022 - 21.11.2026

Rincian metrik lan analitis perusahaan Biomea Fusion (BMEA)

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:Biomea Fusion Corp
Produk mawa merek biomeafusion.com

This indicator is calculated as the sum of cash and highly liquid equivalents, determining the net capital shielded from market volatility. While a high liquidity level minimizes bankruptcy risk, an excessive cash reserve may indicate inefficient resource utilization. For Biomea Fusion, Inc. (BMEA), this reserve is critical for funding clinical trials in oncology and diabetology. The trend in operating cash volume allows for an assessment of the company's autonomy prior to securing new investments.

Analisis perusahaan pesaing

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan FOLD (Amicus Therapeutics Inc)|ETNB (89bio Corp) - Sisa dhuwit perusahaan|Agios Pharmaceuticals - Dhuwit awis perusahaan|Gunggung dana dhuwit perusahaan GPCR (Structure Therapeutics Inc.)|MDXG: Dhuwit awis perusahaan|Rezolute - Gunggung dana dhuwit perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis perusahaan|Dhuwit awis perusahaan MBX Bio|Dhuwit awis perusahaan ALT|AARD: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SGMT|Dana dhuwit perusahaan BIOA (BioAge Labs)|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)